These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25867020)

  • 21. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin.
    Zhong J; Sun P; Xu N; Liao M; Xu C; Ding Y; Cai J; Zhang Y; Xie W
    Biochem Pharmacol; 2020 May; 175():113856. PubMed ID: 32061772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J; Yang SJ; Wang JC; Yang LJ; Xu ZZ; Yang T; Liu XY; Zhang Q
    Eur J Pharm Biopharm; 2010 Oct; 76(2):170-8. PubMed ID: 20600887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
    Broxterman HJ; Feller N; Kuiper CM; Boven E; Versantvoort CH; Teerlink T; Pinedo HM; Lankelma J
    Int J Cancer; 1995 Jun; 61(6):880-6. PubMed ID: 7790125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino Acid Metabolism Abnormity and Microenvironment Variation Mediated Targeting and Controlled Glioma Chemotherapy.
    An S; Lu X; Zhao W; Sun T; Zhang Y; Lu Y; Jiang C
    Small; 2016 Oct; 12(40):5633-5645. PubMed ID: 27571928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma.
    Wang QS; Gao LN; Zhu XN; Zhang Y; Zhang CN; Xu D; Cui YL
    Theranostics; 2019; 9(21):6239-6255. PubMed ID: 31534548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in Transport Characteristics and Cytotoxicity of Epirubicin and Doxorubicin in HepG2 and A549 Cells.
    Nagai K; Fukuno S; Shiota M; Tamura M; Yabumoto S; Konishi H
    Anticancer Res; 2021 Dec; 41(12):6105-6112. PubMed ID: 34848465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo.
    Xiong XB; Huang Y; Lu WL; Zhang H; Zhang X; Zhang Q
    Pharm Res; 2005 Jun; 22(6):933-9. PubMed ID: 15948037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced cytotoxicity in doxorubicin-exposed HepG2 cells pretreated with menthol due to upregulation of P-glycoprotein.
    Nagai K; Fukuno S; Miura T; Uchino Y; Sehara N; Konishi H
    Pharmazie; 2020 Oct; 75(10):510-511. PubMed ID: 33305727
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Qu X; Zhai J; Hu T; Gao H; Tao L; Zhang Y; Song Y; Zhang S
    Xenobiotica; 2019 Sep; 49(9):1116-1125. PubMed ID: 29985077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging.
    Wei L; Tominaga H; Ohgaki R; Wiriyasermkul P; Hagiwara K; Okuda S; Kaira K; Oriuchi N; Nagamori S; Kanai Y
    Cancer Sci; 2016 Mar; 107(3):347-52. PubMed ID: 26749017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
    Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor.
    Zhang J; Zhang H; Jiang J; Cui N; Xue X; Wang T; Wang X; He Y; Wang D
    Int J Nanomedicine; 2020; 15():433-444. PubMed ID: 32021189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursodeoxycholic acid inhibits overexpression of P-glycoprotein induced by doxorubicin in HepG2 cells.
    Komori Y; Arisawa S; Takai M; Yokoyama K; Honda M; Hayashi K; Ishigami M; Katano Y; Goto H; Ueyama J; Ishikawa T; Wakusawa S
    Eur J Pharmacol; 2014 Feb; 724():161-7. PubMed ID: 24370495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen.
    Wang HW; Ma KL; Liu H; Zhou JY
    Aging (Albany NY); 2020 Apr; 12(7):6018-6029. PubMed ID: 32259795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the "optical probe technique".
    Wartenberg M; Hescheler J; Acker H; Diedershagen H; Sauer H
    Cytometry; 1998 Feb; 31(2):137-45. PubMed ID: 9482283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo.
    Barraud L; Merle P; Soma E; Lefrançois L; Guerret S; Chevallier M; Dubernet C; Couvreur P; Trépo C; Vitvitski L
    J Hepatol; 2005 May; 42(5):736-43. PubMed ID: 15826724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.